nigericin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carson, DA; Castro, JE; Choi, MY; Kipps, TJ; Lu, D; Yu, J | 1 |
1 other study(ies) available for nigericin and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.
Topics: Apoptosis; beta Catenin; Calcium; Down-Regulation; Gene Expression Regulation, Leukemic; Genes, Neoplasm; HEK293 Cells; Humans; LDL-Receptor Related Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Low Density Lipoprotein Receptor-Related Protein-6; Nigericin; Phosphorylation; Pyrans; Signal Transduction; Thapsigargin; Wnt Proteins | 2011 |